The combination of phospho-AKT, phospho-MTOR, phospho-MAPK and EGFR predicts survival in non-small cell lung cancer

被引：0
|
作者：
Kitano, Haruhisa [1 ]
Chung, Joon-Yong [2 ]
Ylaya, Kris [2 ]
Takikita, Mikiko [2 ]
Fukuoka, Junya [3 ]
Tezuka, Noriaki [1 ]
Hewitt, Stephen M. [2 ]
机构：
[1] Shiga Univ Med Sci, Dept Thorac Surg, Shiga, Japan
[2] NCI, Tissue Array Res Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
[3] Toyama Univ Hosp, Pathol Lab, Toyama, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2009年 / 4卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S485 / S485
页数：1
相关论文
共 50 条
  • [1] Profiling of Phospho-AKT, Phospho-mTOR, Phospho-MAPK and EGFR in Non-small Cell Lung Cancer
    Kitano, Haruhisa
    Chung, Joon-Yong
    Ylaya, Kris
    Conway, Catherine
    Takikita, Mikiko
    Fukuoka, Junya
    Doki, Yoshinori
    Hanaoka, Jun
    Hewitt, Stephen M.
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2014, 62 (05) : 335 - 346
  • [2] The Expression of Phospho-AKT, Phospho-mTOR, and PTEN in Extrahepatic Cholangiocarcinoma
    Chung, Joon-Yong
    Hong, Seung-Mo
    Choi, Byeong Yeob
    Cho, HyungJun
    Yu, Eunsil
    Hewitt, Stephen M.
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (02) : 660 - 667
  • [3] Expression of phospho-Akt and phospho-MAPK in the adult dorsal root ganglia following axotomy
    Naidu, M.
    Asher, R.
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2006, 24 (08) : 568 - 568
  • [4] Phospho-Akt expression is associated with a favorable outcome in non-small cell lung cancer
    Shah, A
    Swain, WA
    Richardson, D
    Edwards, J
    Stewart, DJ
    Richardson, CM
    Swinson, DEB
    Patel, D
    Jones, JL
    O'Byrne, KJ
    [J]. CLINICAL CANCER RESEARCH, 2005, 11 (08) : 2930 - 2936
  • [5] Increased expression of phospho-mTOR, phospho-p70, phospho-AKT and phospho-ERK in an ovine model of fetal growth restriction.
    Arroyo, Juan A.
    Ziebell, Brad
    Galan, Henry L.
    [J]. REPRODUCTIVE SCIENCES, 2008, 15 (02) : 204A - 204A
  • [6] Phospho-akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage
    David, O
    LeBeau, H
    Brody, AR
    Friedman, M
    Jett, J
    [J]. CHEST, 2004, 125 (05) : 152S - 152S
  • [7] Phospho-Akt overexpression in non-small cell lung cancer confers significant stage-independent survival disadvantage
    David, O
    Jett, J
    LeBeau, H
    Dy, G
    Hughes, J
    Friedman, M
    Brody, AR
    [J]. CLINICAL CANCER RESEARCH, 2004, 10 (20) : 6865 - 6871
  • [8] Prognostic value of phospho-Akt in patients with non-small cell lung carcinoma: A meta-analysis
    Yang, Yang
    Luo, Jialin
    Zhai, Xiaoming
    Fu, Zhiqin
    Tang, Zhongzhu
    Liu, Luying
    Chen, Ming
    Zhu, Yuan
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (06) : 1417 - 1424
  • [9] Improved efficacy of gefitinib therapy in phospho-Akt positive patients with advanced non-small cell lung cancer.
    Cappuzzo, F
    Magrini, E
    Bartolini, S
    Ceresoli, G
    Ludovini, V
    Gregorc, V
    Ligorio, C
    Lombardo, L
    Crinò, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 196S - 196S
  • [10] GEFITINIB IN EGFR FISH POSITIVE/PHOSPHO-AKT POSITIVE AND/OR NEVER SMOKER NON-SMALL CELL LUNG CANCER (NSCLC), CLINICAL AND BIOLOGICAL EFFECTS
    Garcia-Bueno, Jose M.
    Gioseffi, Hernan
    Valls, Agustin
    Saglieti, Sara
    Mas, Jose M.
    Vera, Roberto
    Sanchez-Sanchez, J. L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1236 - S1236
12345